Table 3. Factors Associated With Positive SARS-CoV-2 Test Results Among 226 Neonatesa.
| Variable | Unadjusted | Adjusted | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Maternal SVI ≥90th percentile vs other | 5.49 (2.11-14.29) | .001 | 4.95 (1.53-16.01) | .008 |
| Maternal symptomatic vs asymptomatic COVID-19 | 1.84 (0.51-6.58) | .35 | 0.71 (0.49-1.02) | .07 |
| Vaginal vs cesarean delivery | 0.39 (0.12-1.22) | .11 | 0.47 (0.16-1.40) | .18 |
| Any vs no rooming-in | 0.26 (0.02-3.07) | .29 | 0.29 (0.04-2.29) | .24 |
| Racial/ethnic minority or non–English speaker vs other | 0.81 (0.09-7.66) | .85 | NA | NA |
Abbreviations: NA, not applicable; OR, odds ratio; SVI, Social Vulnerability Index.
a
Mixed-effects regression models accounted for hospital clustering using a robust sandwich estimator. Positive test occurred in the first 5 days after delivery. This analysis includes 6 newborns with a positive SARS-CoV-2 test result within the first week of life (5 positive results during the birth hospitalization, and 1 positive result after discharge on day 5 of life).